Corporate Overview

CEL-SCI Corporation (NYSE MKT: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.

CORPORATE OFFICERS  
   

Geert R. Kersten
Director and Chief Executive Officer

Patricia B. Prichep
Senior Vice President of Operations
Secretary

Eyal Talor, Ph.D.
Chief Scientific Officer

Daniel Zimmerman, Ph.D.
Senior Vice President of Research,
Cellular Immunology

John Cipriano
Senior Vice President of Regulatory Affairs

 

CORPORATE HEADQUARTERS
 
   
CEL-SCI Corporation
8229 Boone Boulevard, Suite 802
Vienna, VA 22182  USA
Telephone (703)  506-9460
Facsimile (703) 506-9471

If you would like to share your feedback with us via e-mail, we invite you to send us your comments or letters to
Feedback@cel-sci.com.
 
   

BOARD OF DIRECTORS
 
   

Geert R. Kersten
Chief Executive Officer
CEL-SCI Corporation

Alexander G. Esterhazy*
Financial Advisor

Peter Young, Ph.D.*
Chief Executive Officer
Agnus Dei, LLC

Bruno Baillavoine*
Executive Chairman
Globomass Holdings Limited

 

* Independent directors and members of the Compensation, Nominating and Audit Committees.

Dr. Young serves as the audit committee's financial expert and chairman of the Compensation, Nominating and Audit Committees.

 

Audit Committee Charter

Nominating Committee Charter

Compensation Committee Charter


 
CERTIFIED PUBLIC ACCOUNTANTS  
   

BDO USA, LLP
Bethesda, MD

 
   

COUNSEL
 
   
Hart & Hart
Denver, CO
 
   

TRANSFER AGENT AND REGISTRAR
 
   

Computershare Investor Services
350 Indiana Street, Suite 800
Golden, CO 80401
(303) 262-0600

 
   

STOCKHOLDERS INQUIRIES
 
   
Inquiries regarding transfer requirements, lost certificates and change of address should be directed to the transfer agent.  
   

STOCK PROFILE
 
   
CEL-SCI Corporation's Common Stock is traded on the NYSE MKT Exchange under the symbols CVM. CEL-SCI also trades on the German Stock Exchanges under the symbol LSR, German Securities Code (Wertpapierkennnummer) 871006.

There are approximately 1,000 stockholders of record as of September 30, 2016. The Company has not paid cash dividends on its Common Stock since its inception.
 
   

SEC FORM 10-K
 
   
A copy of the Company's annual report to the Securities and Exchange Commission on Form 10-K is available without charge upon written request to:

Corporate Communications
CEL-SCI Corporation
8229 Boone Boulevard, Suite 802
Vienna, VA 22182  USA
 
   



Company Code of Ethics

Whistleblower Policy

Shareholder Rights Agreement

 
 


Holders of CEL-SCI's common stock can send written communications to CEL-SCI's entire Board of Directors, or to one or more Board members, by addressing the communication to "the Board of Directors" or to one or more directors, specifying the director or directors by name, and sending the communication to CEL-SCI's offices in Vienna, Virginia. Communications addressed to the Board of Directors as whole will be delivered to each Board member. Communications addressed to a specific director (or directors) will be delivered to the director (or directors) specified.